<DOC>
	<DOCNO>NCT01442948</DOCNO>
	<brief_summary>Monocytes may separate phenotypically functionally distinct cell type presence absence lipopolysaccharide receptor CD14 FcÎ³-receptor CD16 . The investigator hypothesize total number CD16+ monocytes significantly relate cardiovascular outcome patient angiographically proven coronary heart disease .</brief_summary>
	<brief_title>CD16+ Monocytes Coronary Heart Disease ( CHD )</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<criteria>angiographically proven coronary heart disease Age &gt; 18 year life expectancy &lt; 12 month inability participate trial ( give write informed consent )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>-CD16+ monocyte</keyword>
</DOC>